Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youping Deng

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 9, 2015
Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromesElizabeth A McAninch, Sungro Jo, Nailliw Z Preite, et al.
BMC Genomics|December 15, 2010
2K09 and thereafter : the coming era of integrative bioinformatics, systems biology and intelligent computing for functional genomics and personalized medicine researchJack Y Yang, Andrzej Niemierko, Ruzena Bajcsy, et al.
Egastroenterology|October 16, 2025
Immunotherapy against colorectal cancer via delivery of anti-PD-L1 nanobody mRNAWen-Ming Chu, Li Ma, Brian Hew, et al.
Diagnostics (Basel, Switzerland)|January 24, 2020
Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the BladderYoshitaka Itami, Makito Miyake, Sayuri Ohnishi, et al.
Cancer Letters|June 14, 2021
Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patientsYang Chen, Yanyan Li, Changsong Qi, et al.
The Journal of Clinical Investigation|September 26, 2024
TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein MYi Zhou, Shu Zhang, Guoteng Qiu, et al.
Molecular Metabolism|January 23, 2021
Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activationChi Ma, FuKun W Hoffmann, Michael P Marciel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2020
Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, ChinaLing Hu, Shaoqiu Chen, Yuanyuan Fu, et al.
Oncotarget|April 19, 2017
Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladderMakito Miyake, Shunta Hori, Yosuke Morizawa, et al.
Clinical and Translational Medicine|July 27, 2025
A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing dataZitong Gao, Masaki Nasu, Gehan Devendra, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Endocrinology and Metabolism|January 9, 2015
Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromesElizabeth A McAninch, Sungro Jo, Nailliw Z Preite, et al.
BMC Genomics|December 15, 2010
2K09 and thereafter : the coming era of integrative bioinformatics, systems biology and intelligent computing for functional genomics and personalized medicine researchJack Y Yang, Andrzej Niemierko, Ruzena Bajcsy, et al.
Egastroenterology|October 16, 2025
Immunotherapy against colorectal cancer via delivery of anti-PD-L1 nanobody mRNAWen-Ming Chu, Li Ma, Brian Hew, et al.
Diagnostics (Basel, Switzerland)|January 24, 2020
Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the BladderYoshitaka Itami, Makito Miyake, Sayuri Ohnishi, et al.
Cancer Letters|June 14, 2021
Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patientsYang Chen, Yanyan Li, Changsong Qi, et al.
The Journal of Clinical Investigation|September 26, 2024
TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein MYi Zhou, Shu Zhang, Guoteng Qiu, et al.
Molecular Metabolism|January 23, 2021
Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activationChi Ma, FuKun W Hoffmann, Michael P Marciel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2020
Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, ChinaLing Hu, Shaoqiu Chen, Yuanyuan Fu, et al.
Oncotarget|April 19, 2017
Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladderMakito Miyake, Shunta Hori, Yosuke Morizawa, et al.
Clinical and Translational Medicine|July 27, 2025
A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing dataZitong Gao, Masaki Nasu, Gehan Devendra, et al.
Pageof 27